Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A

6(85.7%)

Phase 4

1(14.3%)

7Total

N/A(6)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT07489521Phase 4Recruiting

Arthrosamid vs. Steroid for the Management of Knee Osteoarthritis

Role: collaborator

NCT07465601Not ApplicableActive Not Recruiting

Daily Activity and Clinical Outcome Measurement of Arthrosamid® Administration in Symptomatic Knee Osteoarthritis.

Role: collaborator

NCT04179552Not ApplicableCompleted

PAAG-OA Treatment for Knee Osteoarthritis

Role: lead

NCT04045431Not ApplicableActive Not Recruiting

Treatment of Knee Osteoarthritis With PAAG-OA

Role: lead

NCT05057559Active Not Recruiting

Observational Clinical Investigation of Arthrosamid in Knee Osteoarthritis

Role: lead

NCT03474653Unknown

LATITUDE An Observational Study of Patient Choice and the Urethral Bulking Agent, Bulkamid®

Role: collaborator

NCT00629083Not ApplicableCompleted

Bulking Agents for the Treatment of Stress Urinary Incontinence in Females

Role: lead

NCT00333073Not ApplicableCompleted

Effectiveness and Safety of Bulkamid® as Bulking Agent for the Treatment of Female Urinary Incontinence

Role: lead

NCT00407914Not ApplicableCompleted

Safety and Effectiveness of Aquamid as Compared to Restylane for the Aesthetic Treatment of Nasolabial Folds

Role: lead

All 9 trials loaded